Sodium hydride → HCID 69086142, compound
Reaction equation
[Br-].[Br:2][C:3]1[CH:4]=[N:5][CH:6]=[C:7]([CH2:9]P(C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[CH:8]=1.[H-].[Na+].[F:31][C:32]1[CH:37]=[CH:36][C:35]([F:38])=[CH:34][C:33]=1[C:39](=O)[CH3:40]>O1CCCC1>[Br:2][C:3]1[CH:4]=[N:5][CH:6]=[C:7](/[CH:9]=[C:39](\[C:33]2[CH:34]=[C:35]([F:38])[CH:36]=[CH:37][C:32]=2[F:31])/[CH3:40])[CH:8]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of 3-bromo-5-((tri-phenylphosphino)methyl)pyridine bromide salt (200 mg, 0.337 mmol) in tetrahydrofuran (Volume: 4 mL) was added sodium hydride (90 mg, 0.843 mmol) at 0° C. A half hour later, 2′,5′-difluoroacetophenone (47.0 mL, 0.371 mmol) in tetrahydrofuran (Volume: 1 mL) was added to above solution. Ice bath was removed and heat it to reflux for overnight. Next morning, 10 mL water was added slowly then was extracted by ether (10 mL×3), combined all organic layers, dried over magnesium sulfate, concentrated and obtained a yellow oil which was purified by Preparative HPLC (Preparative HPLC Method 21) and obtained (Z)-3-bromo-5-(2-(2,5-difluorophenyl)prop-1-enyl)pyridine (22 mg, 0.071 mmol, 21.04%). 1H NMR (500 MHz, DMSO-d6) δ 8.45 (d, J=2.1 Hz, 1H), 8.11 (d, J=1.5 Hz, 1H), 7.49 (t, J=2.0 Hz, 1H), 7.36-7.17 (m, 3H), 6.71 (s, 1H), 2.20 (d, J=1.2 Hz, 3H), Mass spec.: 312.1 (MH)+. and (E)-3-bromo-5-(2-(2,5-difluorophenyl)prop-1-enyl)pyridine (18 mg, 0.058 mmol, 17.21%). 1H NMR (500 MHz, DMSO-d6) δ 8.64 (dd, J=6.7, 1.8 Hz, 2H), 8.11 (t, J=1.8 Hz, 1H), 7.38 (ddd, J=9.3, 6.1, 3.2 Hz, 1H), 7.32 (td, J=9.7, 4.7 Hz, 1H), 7.28-7.21 (m, 1H), 6.72 (s, 1H), 2.23 (t, J=1.5 Hz, 3H), Mass spec.: 312.1 (MH)+.
Workup
- customIce bath was removed
- temperatureheat it
- temperatureto reflux for overnight
- additionNext morning, 10 mL water was added slowly
- extractionthen was extracted by ether (10 mL×3)
- dry with materialdried over magnesium sulfate
- concentrationconcentrated
- customobtained a yellow oil which
- customwas purified by Preparative HPLC (Preparative HPLC Method 21)
Sources & evidence
- ORD record
- ord-723eb51e582d4ebbbbf52613c7dd35a4
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691821B2
Reaction notes
Loading…